North America Epigenetics Market Research Report – Segmented By Product, KITS, Reagents, Research Area, Country (the United States, Canada and Rest of North America) - Industry Analysis, Share, Size, Trends, COVID-19 Impact & Growth Forecast (2024 to 2032)

Updated On: June, 2024
ID: 1882
Pages: 145

North America Epigenetics Market Size (2023 to 2032)

The North America Epigenetics Market was valued at USD  233.37 million in 2023. The North America Epigenetics Market is expected to have 12.8 % CAGR from 2024 to 2032 and be worth USD 689.96 million by 2032 from USD 263.24 million in 2024.  

Rising cancer prevalence, and increased research and development activities, and growing applications in Epigenetics are majorly promoting the growth rate of the North American epigenetics market.  Also, the financing for epigenetics research and developing uses of epigenetics in non-oncology illnesses contribute to the market growth. Moreover, Cancer is the second most common cause of mortality in the United States, accounting for almost one out of every four fatalities. 

In the coming years, the expanding application areas of epigenetics in non-oncology illnesses, customized medicine, and target treatment are likely to create potential possibilities for market participants. Also, increase in the risk of cardiovascular diseases and an increase in the investments in research and development practices. 

The market expansion is hampered by the high cost of instruments, a scarcity of skilled specialists. Also, the scarcity and lack of financing plans and awareness about epigenetics impede market growth.

This research report on the North America Epigenetics Market has been segmented & sub-segmented into the following categories

North America Epigenetics Market - By Product

  • Enzymes

  • Instruments & Consumable

  • KITS
  • Reagents

North America Epigenetics Market - By Research Area

  • Developmental Biology

  • Oncology

  • Drug Delivery

North America Epigenetics Market - By Enzymes

  • DNA-Modifying Enzymes

  • Protein-Modifying Enzymes

  • RNA-Modifying Enzymes

North America Epigenetics Market - By Instruments & Consumables

  • Mass Spectrometers

  • Next-Generation Sequencers

  • qPCR
  • Sonicators

North America Epigenetics Market - By KITS

  • Bisulfite Conversion KITS

  • Chip-Sequence KITS

  • RNA Sequencing KITS
  • Whole-Genome Amplification KITS
  • 5-HMC and 5-MC Analysis KITS

North America Epigenetics Market - By Reagents

  • Antibodies

  • Buffers

  • Histones
  • Magnetic Beads
  • Primers

North America Epigenetics Market - By Country

  • The U.S.

  • Canada

  • Rest of North America

Geographically, North America dominated the global market in 2023 due to its advanced technology and significant presence.

The U.S. Epigenetics Market is estimated to account for the most significant share in the North American epigenetics market during the forecast period. Y-O-Y growth in cancer incidence is majorly accelerating the epigenetics market in the United States. In addition, enlarging epigenetics applications in non-oncology diseases, personalized medicine, and target therapy are further anticipated to boost the market's growth rate. 

The Canadian epigenetics market is predicted to be another lucrative regional market in the North American market during the forecast period. The increasing obesity population, growing research on oncology diseases, and increasing collaborations between research institutes, biotechnology, and biopharmaceutical companies are estimated to support Canada's market growth. 

KEY MARKET PLAYERS

A few of the notable companies playing a leading role in the North America epigenetics market are Abcam plc., Illumina, Inc., QIAGEN N.V., Merck & Co., New England Biolabs, Inc., Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Active Motif, Diagenode, Inc., and Zymo Research Corporation.

Please wait. . . . Your request is being processed

Anil Kumar P is research manager at Market Data Forecast and responsible for Healthcare Domain.

Author

Anil Kumar P (Research Manager - Healthcare)

Anil Kumar P is the lead author of this report and the manager of the team responsible for authoring healthcare reports at Market Data Forecast. He holds a Bachelor’s degree in Pharmacy (Hons.) from BITS Pilani, one of India’s premier institutions. Over the past seven years, Anil has gained extensive experience working with multiple market research companies, where he has collaborated with a diverse range of clients—from innovative startups to Fortune 500 companies—delivering data-driven insights and strategic advice that drive business growth.

Read More

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample